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Basal cell carcinoma (BCC) places increasing burdens 
on clinicians; incidence is rising and patients m.ay 
develop multiple primary tumors. Although UV ex-
posure is critical, lnany patients develop tumors at 
less-exposed sites, such as the trunk, suggesting a 
genetic predisposition. We previously showed that 
polymorphism ill. loci encoding the detoxifying en-
zymes, glutathione S-transferase (GSTM1, GSTM3, 
GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) 
influences susceptibility to BCC. We now describe a 
case-control approach in 345 patients with BCC that 
examines the role of these polymorphisms and pa-
tient characteristics (age, gender, skin type, hair 
color, eye color, smoking, occupation) in determin-
ing susceptibility to truncal tumors. GST and CYP 
genotypes were identified using polytnerase chain 
reaction-based 11lethods. Patients with one or more 
truncal tun1.0rs were significantly younger (p = 
B asal cell ca rcin om a of skin (B CC) is the commonest cancer in Ca ucasians, accounting in 1994 fo r abo u t 35'X, of all newly diagnosed neoplasm s in the United States (Borin g c ( ai, 1993, 1994; Mille r and W ein-stock , 1994) . A re markable feature o f this pathology is 
th e ri sk suffe red by patients of develo ping furth er tumors at 
d iffe rent sites . Impo rtantl y, this ri sk depends on the number of 
les ions already presen t; 27% of patien ts w ith o ll e tumo r will suffe r 
a further tumo r w ithin 5 y compared with 90% in those w ith 10 o r 
more lesions (Kri cker c ( ai, 1993) . Exposure to ultravio le t radi ation 
(UV) is recognized as a cri tica l fa c to r in th e pathogenesis of BCC 
(Kricker c( ai, 1993; Kripke, 1994; Kara gas and Greenberg, 1995). 
al th o ugh the re lationship be tween am ount, timing, and nature of 
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0.0170) than those with no truncal tumors. Male 
gender also appeared more common in the truncal 
tumor group, although this did not achieve signifi-
cance (p = 0.0925). Patients whose first tumor was 
truncal had significantly more tumors (p = 0.0297). 
GSTTl null (p = 0.0245, odds ratio 2.24) and CYP1Al 
De/De (p = 0.0386, odds ratio 2.86) were associated 
with truncal site after correction for age and gender. 
The combination, GSTT1 null and CYP1A1 De/De, 
was particularly significant (p = 0.0059, odds ratio = 
2.95). The se effects were present after correction for 
tumor numbers. These data show first, patients with 
truncal tumors constitute a high-risk group for BCC, 
second, a significant genetic influence on BCC site, 
and third, a significant interaction between GSTT1 
and CYP1A1 genotypes. Ke}1 words: gelletic pJ'edisposi-
tiouldeto.dj'yillg ellzYlll eslpoIYllloJ'pir.islll. ] ['",est D el'llJatol 
108:519-522, 1997 
exp Osure and ri sk is complex and poorly understood . Indeed . 
compared with cutaneo us squ am o us cell can cer , BCC are m ore 
commOn o n gen erally less- e :-.:p osed sites. especially tlle trunk 
(Kricker e( ai, 1993; Karagas and Greenberg, 1995), w ith lesio ns 
infrequentl y fo und o n the fo rearms or ba cks o f th e hands. Also . 
whereas the inciden ce o f BCC is increasing , it is tll e pro portio n o f 
tumors o n th e trunk that dem on strates the grea tes t in crease 
(Kricker c( ai, 1993) . Together , these d ata su ggest that suscep tibility 
to BCC is dependen t not merely on U V exposure but also on host 
genetic f.'1ctors. T his view is suppo rted by data sho wing suscepti-
bili ty to UYB-induced illhibition o f con tact hypersensitivity appea rs 
to be a be tte r indicator of no n-melanoma skin can cer risk than 
cumulative UY exposure (Schmieder et al. :1 992). 
Because UV exposure is a cri tical facto r in the pa thogenesis o f 
BeC (Kripke, '1994; Karagas 'lI1d Greenberg, 1995), facto rs that 
m ediate indi vidual resp onse to the ple io tro phk e ffects o f radiatio n 
arC candidates fo r susceptibili ty to BCC. T hus, skin type and m ale 
gender arc recognized as ri sk facto rs (Kricker c/ ai, 1993). T he 
concept o f susceptibili ty. however, is complex because gene tic 
facto rs, as w e ll as influ en cin g BCe ri sk in indi viduals witho ut 
tum ors, m ay also influence tumor numbers. rate o f appearance o f 
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tumors (accrual), and their site. We have studi e d genetic predis-
position to BCC using each of these ri sk parameters. Some 
promising candidates for BCC risk are identified, polymorphism in 
genes involved in re pair ofUV-damaged DNA and detoxification 
of the products of oxidative stress be ing signifi can t (Heagerty et ai, 
1994; Wei e/ ai, 1994; Heagerty el ai, 1996; Lear el ai, 1996). Thus, 
we have shown that polymorphism at detoxifying e nzym e gene loci 
such as members of the glutathione S-transferase (GSTM 1 nulJ , 
GSTM3 AA, and GSTT1 nuU genotypes) and cytochrome P450 
(CYP2D6 EM and CYP1A 1 m1 m1 genotypes) supergene f.1mil ies, 
as well as patient c haracteristics such as skin type 1, mediate 
susceptibility to increased numbe rs of pl'imary tumors and their rate 
of accrual (Lear c/ ai, 1996; Yengi e/ ai, 1996). GSTM 1, GSTM3, 
and GSTTl appear attractive candidates, becau se these enzymes 
utili ze the products of oxidative strcss-induced d am age to DNA 
and lipids . Both C YFIA1 and its ligand-dependent transcription 
factor, the Ah receptor, are widely expressed in extrahe patic tissues 
including skin (Rauluo el ai, 1995) , and although the gene has 
large ly been studied in the context of environmental pollutants 
(e.g., polycyclic aromatic h ydrocarbons), there is evidcnce that its 
products utilize e ndogenous ligands and participate in defense 
against oxidative stress (Nebert, 1994; Smith el ai, 1995). The role 
of CYP2D6 is uncl ear (Inge lman-Sundberg and Johansson, 1995) . 
Its expression is mainly hepatic and although found in brain and 
intestine, it has not bcen detected in skin (Raunio el ai, 1995). The 
assoc iation between CYP2D6 PM and susceptibility to Parkinson's 
disease, however, suggests ill lIillo substrates that include e ndoge-
nous neurotoxins and mol ecules containing amine or guanidino 
group s (Guengerich, 1995 ; Smith el a', 1995). Further, becau se 
systcmic agcnts such as arsenic predispose to multip le BCC (Yeh el 
ai, 1968), CYF2D6-mediated hcpatic detoxifi cation of photosensi-
tizing agcnts may be important. 
Because the trunk is less exposed, or at leas t inte rmitte ntly 
exposed, to UV, it could be hypothesized that p atients with truncal 
tumors re present a hig h-risk group beca use they are less able to 
handle the produ cts of UV -induccd damage. Little research has 
addressed this issue or investigated possible diffe rences in individ-
uals with and without truncal tumors, although it is known that 
expos urc to arsenic-containing tonics predisposes to trunc;11 tumors 
(Yeh el ai, 1968), supporting the view that factors other than UV 
alone may be important. We hypothesize that the presen ce of 
truncal tumors is more strongly assoc iated with genetic susceptibil-
ity. Accord in gly, we now describe studies to investigate genetic 
differences and individual chara cteri stics iJl patients with and with-
out truncal tUJ11ors. 
MATERIALS AND METHODS 
Patients T he influence of genotypes and chnractcri stics on tlll110r site \"'as 
studied in 345 unrelated Northern European Callc"sians with hjstologically 
proved BCC. They were recruited [rom Dermatology clinics in the North 
Staffordshire Hospita l. Stafford District Genera l Hospiwl , and R.oya l Corn-
wall Hospitals. Offirst tumors, 80.1')1" were on the he"d/ncck. I 1.4% were 
trunc:!I. 6.S/Yo were lo'\vcr lilllbs, and the rCI11aining 2 .0tX, were o n the upper 
limbs; '170 patients suffered one tUlll or and '175 patients between two and 30 
rumors. Itecurrences were excl uded fTom the tot,1i number of primary 
13CC. No pa tients with basa l cell nevus syndrome . xeroderma pigmento-
SUI11, or DCC and another malignancy (cutaneous or in ternal) were 
included . None of those approached refused to participate. A.II patients were 
examined and interviewed by a trained dennatolngist U.T.L., A.S., 
A.H.M.H.) to obta in information on hair (blonde/red and brown/black) 
and eye color (blue/green and brown) at 2:1 y of age. skin type (types 1-4). 
occupation (indoor/outdoor) , smoking hi sto ry (ever/ never smokers) (Lear 
('I nl. 1996). as well as the time between tumor appearance and presentation 
to a physician. Pacicllts were also questioned regarding ingestion of arscnic-
cOlltaining to rti cs and lI SC of drinkin g water fro nl potenb ~llI y cOlltalninatcd 
wells. No arsen ic-exposed patients were identif,ed. 
Idcnti1ieation of GSTM1, GSTM3, GSTT1, CYP2D6, and CYl)lAl 
Genotypes Blood (5 ml) was t"ken with Ethics Commi ttce "pprova l into 
ethylenediaminc tct.-aacetic acid and stored at - SO°C. GSTM l null, A, 13, 
and A/B werc identified using a polymerase chain reaction approach (Lear 
1'1 ti l. I 996). GSTM3 genotypes were identified usin g primers to exon 6/7 
(Yengi ct nl. 1996). GSTM3*B was difFerentiated from GSTM3*A by 
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Table I. Patient Demographics 
Patients with No Pa tients with at Least 
Trunc al Tunlors One Truncal T umor 
Mean age (y) 68.3 :': 12.2 (SO) 66 .2 :': 11.9 (SD) 
(n = 263) (n = 74) 
Males S4.1 % (n = 268) 64.9% (n = 77) 
Mean BCC no. I. 99 :': 1.81 (SO) 5.40 :': 6.03 (SD) 
(n = 270) (n = 75) 
13Iue and grecn eyes 70.1 'v., (n = 148) 75.8'10 (n = 47) 
Brown eyes 29.9% (n = 63) 24.2% (n = 15) 
Skin type 1 16.4% (n = 34) 16.9'X. (n = 10) 
Skjn type 2-4 83.6% (n = 173) 83.1% (n = 49) 
Ever smoker 65.1 % (n = 142) 62.9% (n = 39) 
Never slllokcr 34.9% (n = 76) 37. 1% (n = 23) 
Brown and black hair 74.8% (n = 101) 64.1 % (n = 25) 
Blonde and red hair 25.2% (n = 34) 35.9"1., (n = 14) 
Outdoor occupation 16.7% (n = 13) 19.2% (n = 5) 
1ndoor occupation 83.3% (n = 65) 80.8% (n = 21) 
digestion with Mnll. GSTTl null and expressers were also identified by 
polymerase chain reaction (Lc:,,' el til. 1996). Two mutant CYP2D6 alleles 
(G-A tra"sition at intran 3/exon 4, base pair deletion in exo ll 5) were 
identified (Lear "I nl, '1996). Together these assays arc abollt 90% predictive 
of phenotype in Euro pea n Ca ucasians (Lear "I nl. 1996). Two mutant 
CYP1 A 1 alleles (exoll 7 lie-Val and 3' -flanking region iVlsl' 1 mutations) 
were detected using polymerase elwin reaction (Lear 1'1 nl, 1996; Yengi el al. 
1996) . 
Statistical Analysis T tests were used to assess differences in ages and 
Ilultlbe r of BCCs betweell the two g ro ups. X2_tcsts were Ll sed to examin e 
tor ho nlogcncity between cases ,",vith and without at lea st o ne trun c:" tumor. 
As some genotype frequencies were small , the StatXact-Turbo statistical 
package was used to obtain exact p va lues. As various f.,cto rs (GSTM l. 
GSTM3. GSTT1. C YP2D6. C YPI Al, gender. age. skin type. eye color. 
hair color, slllokill g statll s. occupation) were studied. the. i_I1Aucl1 cc on 
tU1110[ site of eac h alone and in cOJ1lbillatio li was studied by logistic 
regression nrw lys is. COlnbinations of genotypes and c haractc ri srics were 
studi ed ill the prese llce of the maill e flccts. and ollly those ill which rhe 
interactive ternl \\'as 111 0 re sig ni fica nt t han e ither of the Illain effects were 
included. For example. the combillatio ll GSTT I 1Il,II + CYP I A I li e/ lie was 
considered ill the prese ll ce of GSTT I null alone and C YP I A I lie/ lie alone. 
.BcC<luse age and gender were sig nifi cant confou nding f..1cto rs . analysis of the 
inAucnce of genotypes and other pat.ient characte ri stics were correc ted for 
these factors. S il1 ce patients with at least o ne trul1 c al tUlnor suWcr more 
DCC. the associations with tumor site were furrher allalyzed by cO 'Tecrion 
for BCC number as well as agc and gendcr. 
RESULTS 
COinparison of Patient Characteristics between Truncal 
and Nontruncal Groups Table I shows the characteristi cS of 
the study groups. The m ean age at presentation of paticnts with ar 
lea st o n e truncal tumor was lower than those without truncal 
tumors rp = 0.0170, X2 , = 5.70, odds r;nio = 0.975, 95% 
confidence in tcrva l (CI) = 0.955, 0.995]. and the pro po rtion of 
males was g reater although this did not reach signifi ca ncc (p = 
0.0925, X2 , = 2.83, odds ratio = "1.571. 95% C I = 0.928, 2.659). 
The number of13CC in patients Witll at least one trunca l tulllor was 
g rcate r than the nontrunca l tumor group because the larger the 
number of tumors, the greater the probabi li ty tllat one will be 
truncal. T hc mean number of primary tumors in patients whose first 
tumor was truncal (II = 40; mean tulllor numbcr ± SD = 3.96 ± 
4.74), however, was also significantly greater than those whosefirsl 
tumor was not truncal (n = 312; mean tum or number ± SD = 
2.58 ± 3.32; P = 0.0297. X2, = 4.73 , odds rati o = 1.079. 95'X) C I = 
1.008, 1.156). Other patient chara cteristi cs (skin type, eye color, 
smokillg. occupation, hair color) were not sig nificantly different 
between the two groups, although the presence of red or blonde 
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Table II. Factors Demonstrating Significant Differences 
between Patients with at Least One Truncal Tumor and 
Those with No Truncal TUlllors" 
p Value X2 Odds Ratio 95')1" C I 
GSTTI Ilu ll 0.U245 5.06 2.24 1. 11-4.53 
CYPl A1 lie/ lie 0.0386 4.28 2.86 1.06-7.72 
GSTII null + C YPIAl 
lie/ li e U.OO59 18.70 2.95 1.:17-6.3\1 
.1 Dalrl arc correc ted for age ~lIld gellder. 
hair, corrected for age and gender, approached significance (p = 
0.0974). 
Genetic Factors Associated with the Presence of Truncal 
Tumors Table II shows the genotypes, corrected for imbalances 
in patient age and gender, associated w ith tumor site. By logistic 
regress io n , the age-corrected proportion of GSTTI null and 
CYPI A J lie/ fi e geno types was signi fica ntly g reater in patients w ith 
at least one tl"Un cal tumor. T he importance of GSTTI and C YPI Al 
genotypes is furth er emphasized by the increased signifi cance o f the 
interaction (the co mbina tion of both GSTTI null and CYP1. A 1 
lie/lie) . In order to further assess the impo rtance of these genotypes 
as determiJlants of tumor site, the associations w ith tumor site were 
also corrected fo r BCC number as well as age and gender, beca use 
patients w ith at least one tl"Uncal tumor sufFer m ore BCC (Table I) . 
T his demon strated that indi vidua ll y, both GSTTI nuLl ,md 
CYPI A 1. lie/li e remain ed significa n t bu t w ith reduced odds ratios 
(p = 0.0316, odds ratio = 1..44, 95";', C I = 1.24, 1.66, and p = 
0.0130, odds ratio = 1.5 1,95% C I = 1.29 -1.77 , respectively). T he 
combination of these genotypes (both GSTTI null and CYPIA :I 
lie/fie), however , remained highl y significant, with a decreased p 
va lue and increased odds ratio (p = 0 .0035, odds ratio = 3.56, 95'li" 
C I = 1.52-8.34) desp ite this rigorous correction . None of the other 
genotypes exam ined (GSTMI null , GSTM3 AA, CYP2D6 EM , and 
CYF1Al ml ml) was associa ted w ith tumor site, e ither alon e or in 
combination with other genotypes o r patient characteristics. 
DISCUSSION 
We have studied the influ ence of detoxi fying enzym e genotypes 
and patient charac teristics on the development of trunca l BCC by 
comparing these facto rs in patien ts with at least one truncal BCC 
and those with no trunca'! tumors. ncc are a major burden to 
hea lth care agencies, w ith an incidence in the United States as high 
as 300 per 100,000 people and reported annual increases of abo ut 
10% (Karagas and Greenberg, 1995) . In view of this high and 
increasing incidence, and because m orta li ty is low, it is predicted 
the prevalence of this tumor w ill be g reater th an that for all other 
cancers combined (Boring el ai, 1994). T hus, the lifetime risk of 
BCC for an American child bo rn in 1994 is estimated to be 28 - 33% 
(Mill e r and Weinstock, '1994). Further. alth ough exposure to UV is 
a recognized ri sk facto r, o ur data show that about 20'Yr, of patients 
w ith BCC develop at least o ne tumo r at sites genera lly believed to 
suffer relative ly little expos ure. 
The mean age at first presentation of patients with at lcast one 
trunca l tumor was lower than in those w ith no tru nca l tumors. 
Furthermore, patients w hose first tumor is truncal are at in creased 
risk of further tum ors, suggestin g tha t patients with trun ca l tumors 
represent a high-ri sk gro up . T he in creased prevalence of males in 
the trunca l compared w ith the non tru nca l tumor gro up suppo rts 
our loca l clinica l impress ion , although this fa iled by a small m argin 
to achieve statistica l significance . T his is consistent with the 
association of both mal e gender and truncal tu m o r site with 
increased ri sk of multip le tumors (Lear ci ai, 1996). Outdoor 
occu pation was not a signi fica nt f:lctor in o ur ana lysis, suggestin g 
that males do not have increased chro ni c UV exposure compared 
with females. Other exp lanations for the in creased ri sk associa ted 
w ith ma le gender , such as less effective melanization than fe l1lales 
(McLeod ef ai, 1994), are worthy of investigation. 
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Sin ce both age and gender were signi fica n t confounding factors, 
data on the influence of genotypes and patient chara cteristics were 
corrected for imbalances in these factors. Fo llowin g correction , 
n one of the patient characteristics studied were associated with 
tu mor site . In particular, skin type 1 was not significantly diR:"erent 
bet\veen the two groups, suggestin g that patients w ith truncal 
tumors are no more likely to burn o n UV exposure than patients 
w ith no ntrunca l tumors. 
Analysis of the ro le of detoxifYing enzymes in determining tumor 
site showed that GSTTI and CYPI A 1 arc important. even after 
correction for BCC number as well as age at first presentation 'lnd 
gender. Altho ugh the level of significance of th ese factors was 
re la tive ly low, the in fl uen ce of the highly si!,'nificant interactive 
ternl (both GSTTI null and CYPI A 1. Il e/ lle) suggests th e effects 
arc rea l. We have previously shown that GSTT1, w hose enzyme 
substrates inc.lude the prod ucts of oxidative stress-induced damage 
to DNA, is significan tly associated with rate of accru al of BCC in 
patients w ith multiple tumors (Lear el aI, 1996). T he data presented 
here support tlle view that GSTTI n ull genotypes are associated 
with faste r appearan ce of further tumors and the presence of trun cal 
tumors . T hu s, it appear.s th at thi s genotype exerts its effect on th e 
rate of BCC appeara nce, because it predisposes to tumors on bot.h 
ch ronica lly and intermi tten tl y exposed sites. T hese data suggest that 
individu als deficient in the abi li ty to repair UV-derived oxidative 
stress-indu ced damage to DNA and / or lipids arc gen etica lly pre-
disposed to BCC and arc m o re likely to develop subsequent 
tumors. GSTTI nu.ll individual s may b e m ore susceptible to 
UV-induced BCC to llowing even relatively li ttle UV exposure, 
resultin g in an in creased number of tumors at a younger age and the 
developmcnt of les ions o n intermittently exposed sites such as the 
trunk. Unl ike GSTTI null , however, no GSTM1 null effect was 
identified, com plem enting data showing t11at th e produ cts of these 
loci have some differences in substrate specificities (Norppa ('I ai, 
1995). 
Data showing that UV-oxid ized t"yptophan binds to the 
CYP1A 1 ligand-dependent Ah receptor transcrip tion factor and 
UV induces CYP1 A 1 expression in skin suggest a role for allelism 
at this locus in skin carcinogenes is (Gonzalez, 1995). The influence 
of CYPI Al Ile/ Ile on tum or site shown here is more difricul r to 
interpret than the GSTT] effect, beca use we have shown that. this 
genotype was associated with slower BCC accru al, although this 
efFect was relatively weak. It is not known w hether CYl)1 Al is 
uniformly expressed in skin; UV is kn own to induce expression, 
suggestin g that di ffe ren tial effect in chronica lly and intemlittently 
exposed skin is possible. 
Although interactions between GSTM 1 and CYPI A 1 have been 
identified in media ting risk of lung cancer (A nttila CI ai, 1994), this 
repo rt describes <1n interaction between GSTTI and C YPI AJ. 
Indeed, particularly after co rrection for age, gender, and BCC 
number, the odds ratio for this eR:"ect (3.56) was re latively high . 
T his study presents further evidence that patients with truncal 
tumo rs represent a high-risk group and that factors other than UV 
exposure arc importan t in the pathogenesis of these tumo rs. 
1Vc .Qra l~f;tfl )' arkll", .. /rd,Qc 1/,,· slIp/)ort <1"1/11' CII IICI'r R"St'arc/J C al/lpaigll /pmjecl 
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